156 related articles for article (PubMed ID: 19142185)
1. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?
Grazzini G; Visioli CB; Zorzi M; Ciatto S; Banovich F; Bonanomi AG; Bortoli A; Castiglione G; Cazzola L; Confortini M; Mantellini P; Rubeca T; Zappa M
Br J Cancer; 2009 Jan; 100(2):259-65. PubMed ID: 19142185
[TBL] [Abstract][Full Text] [Related]
2. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
3. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
[TBL] [Abstract][Full Text] [Related]
4. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood.
Castiglione G; Grazzini G; Miccinesi G; Rubeca T; Sani C; Turco P; Zappa M
J Med Screen; 2002; 9(3):99-103. PubMed ID: 12370319
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
6. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests.
Castiglione G; Zappa M; Grazzini G; Rubeca T; Turco P; Sani C; Ciatto S
J Med Screen; 2000; 7(1):35-7. PubMed ID: 10807145
[TBL] [Abstract][Full Text] [Related]
8. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening: why immunochemical faecal occult blood test performs as well with either one or two samples.
Guittet L; Bouvier V; Guillaume E; Levillain R; Ruiz A; Lantieri O; Launoy G
Dig Liver Dis; 2012 Aug; 44(8):694-9. PubMed ID: 22525156
[TBL] [Abstract][Full Text] [Related]
12. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
Rozen P; Knaani J; Samuel Z
Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
Hundt S; Haug U; Brenner H
Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
[TBL] [Abstract][Full Text] [Related]
15. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
[TBL] [Abstract][Full Text] [Related]
16. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme.
Clark G; Strachan JA; Carey FA; Godfrey T; Irvine A; McPherson A; Brand J; Anderson AS; Fraser CG; Steele RJ
Gut; 2021 Jan; 70(1):106-113. PubMed ID: 32234803
[TBL] [Abstract][Full Text] [Related]
17. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area.
Cariou M; El Fettouhi A; Kermarrec T; Bommelaere F; Foll Y; Nousbaum JB; Robaszkiewicz M; Quénéhervé L
Cancer Epidemiol; 2020 Dec; 69():101839. PubMed ID: 33096500
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions.
Castiglione G; Sala P; Ciatto S; Grazzini G; Mazzotta A; Rossetti C; Spinelli P; Bertario L
Eur J Cancer Prev; 1994 Sep; 3(5):399-405. PubMed ID: 8000308
[TBL] [Abstract][Full Text] [Related]
20. Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening.
Dancourt V; Hamza S; Manfredi S; Drouillard A; Bidan JM; Faivre J; Lepage C
Eur J Cancer Prev; 2016 Mar; 25(2):109-14. PubMed ID: 25830897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
